Alterations of Raman Profiles of Cystic Echinococcosis Serum After Treated With ABZ by SERS
Related Experiment Video
Updated: Aug 6, 2026

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
Ziyi Fang1,2,3, Shengke Xu1,2,3, Shaoquan Xu1,2
1State Key Laboratory of Pathogenesis, Prevention, and Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Abstract:
Cystic echinococcosis (CE) is often treated with albendazole (ABZ). Surface-enhanced Raman scattering (SERS) has high sensitivity and specificity, as well as low sample consumption, but its ability to identify changes in serum compounds post-ABZ treatment is unclear. This study used SERS to characterize the Raman profiles of serum from 7 normal, 9 CE-model, and 10 ABZ-treated mice, analyzing profile differences. Tentative peak assignments revealed ABZ-induced biomolecular changes in protein structure (1000 cm-1), uric acid (1130 cm-1), amide III (1203 cm-1), phospholipids, and amide I (1656 cm-1). The top 10 principal components (PCs) accounted for 90% of the variance (PC1: 48.9%). Principal components analysis (PCA) loadings suggested these substances as markers of ABZ treatment. The results show that SERS combined with PCA is a rapid and effective method to observe serum changes in Echinococcus granulosus-infected subjects.
More Related Videos
08:34Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
Published on: July 27, 2022
06:50A Soluble Tetrazolium-Based Reduction Assay to Evaluate the Effect of Antibodies on Candida tropicalis Biofilms
Published on: September 16, 2022